Po COVID-19 pandemijos mRNR technologija tapo vienu svarbiausi\u0173 prover\u017ei\u0173 medicinoje, ta\u010diau Europoje vis da\u017eniau keliami klausimai, ar \u017eemynas turi pakankamai gamybini\u0173 paj\u0117gum\u0173 kitai krizei. \u201eModerna\u201c vadovas St\u00e9phane\u2019as Bancelis teigia, kad rizika i\u0161lieka tiek d\u0117l nat\u016braliai kylan\u010di\u0173 virus\u0173, tiek d\u0117l \u017emogaus sukelt\u0173 gr\u0117smi\u0173.<\/p>\n
Pasak jo, pandemija gali prasid\u0117ti netik\u0117tai, o svarbiausias veiksnys tada tampa greitis, per kur\u012f galima pagaminti ir pristatyti vakcinas. \u201eModerna\u201c vadovas pabr\u0117\u017eia, kad \u0161iandien pasaulyje infrastrukt\u016bra jau geresn\u0117 nei 2020 metais, nes \u012fmon\u0117 turi i\u0161pl\u0117tot\u0105 gamybos tinkl\u0105 keliose \u0161alyse.<\/p>\n
St\u00e9phane\u2019as Bancelis atkreipia d\u0117mes\u012f \u012f tendencij\u0105, kuri\u0105 jis vadina pavojinga Europai: mRNR vakcin\u0173 gamyba vis labiau koncentruojasi u\u017e \u017eemyno rib\u0173. Jis vie\u0161ai \u012fsp\u0117jo, kad \u017eemynin\u0117je Europoje gali nebelikti pakankamos pramonin\u0117s baz\u0117s, kuri leist\u0173 greitai sureaguoti \u012f nauj\u0105 u\u017ekrat\u0105.<\/p>\n
Diskusij\u0105 kaitina ir tai, kad dalis COVID-19 laikotarpiu Europoje i\u0161augint\u0173 paj\u0117gum\u0173 persitvarko arba ma\u017eina apimtis, o gamyba pereina prie pasaulini\u0173 partneri\u0173 modelio. Tokia kryptis rei\u0161kia, kad kriz\u0117s metu Europa gali labiau priklausyti nuo importo, tiekimo grandini\u0173 ir kit\u0173 region\u0173 sprendim\u0173.<\/p>\n
\u201eJei Europoje nutikt\u0173 ka\u017ekas labai blogo, gali paai\u0161k\u0117ti, kad n\u0117ra pramonin\u0117s baz\u0117s, kuri leist\u0173 su tuo kovoti\u201c, \u2013 sak\u0117 St\u00e9phane\u2019as Bancelis.<\/p>\n
\u201eModerna\u201c, kaip ir kitos mRNR platform\u0105 vystan\u010dios biotechnologij\u0173 \u012fmon\u0117s, po pandemijos siekia ma\u017einti priklausomyb\u0119 nuo COVID-19 vakcin\u0173 paklausos. \u012emon\u0117 orientuojasi \u012f platesn\u012f produkt\u0173 portfel\u012f, \u012fskaitant infekcini\u0173 lig\u0173 vakcinas ir onkologijos krypt\u012f, kur mRNR technologija vertinama kaip galimyb\u0117 kurti labiau individualizuot\u0105 gydym\u0105.<\/p>\n
Vienas i\u0161 akcent\u0173 \u2013 projektai, susij\u0119 su paveldimomis b\u016bkl\u0117mis, didinan\u010diomis onkologini\u0173 lig\u0173 rizik\u0105, pavyzd\u017eiui, Lyncho sindromu. \u0160i genetin\u0117 b\u016bkl\u0117 siejama su sutrikusiu DNR klaid\u0173 taisymu ir didesne tam tikr\u0173 v\u0117\u017eio r\u016b\u0161i\u0173 tikimybe, tod\u0117l prevencin\u0117s ar ankstyvos intervencijos sprendimai laikomi ypa\u010d svarbiais.<\/p>\n
\u201eCOVID-19 pandemija mus trumpam nukreip\u0117 nuo kelio, bet po to gr\u012f\u017eome prie misijos: mRNR gali tapti vaist\u0173 pagrindu daugelyje sri\u010di\u0173 \u2013 nuo v\u0117\u017eio iki infekcij\u0173 ir ret\u0173 lig\u0173\u201c, \u2013 sak\u0117 St\u00e9phane\u2019as Bancelis.<\/p>\n
Ekspert\u0173 vertinimu, pandemij\u0173 pasirengimas \u0161iandien apima ne tik vakcin\u0173 k\u016brim\u0105, bet ir gamybos paj\u0117gum\u0173 i\u0161laikym\u0105, \u017ealiav\u0173 tiekim\u0105, reguliacini\u0173 proced\u016br\u0173 spart\u0105 bei nuolatin\u0119 steb\u0117sen\u0105. Augant nerimui d\u0117l biologini\u0173 gr\u0117smi\u0173 ir spart\u0117jant technologij\u0173 raidai, Europos geb\u0117jimas gaminti kritines medicinos priemones savo teritorijoje tampa strateginiu klausimu.<\/p>\n","protected":false},"excerpt":{"rendered":"
\u201eModerna\u201c vadovas persp\u0117ja, kad Europai tr\u016bksta mRNR gamybos baz\u0117s, o tai gali kainuoti brangiai kilus naujai pandemijai ar biogresmei.<\/p>\n","protected":false},"author":0,"featured_media":37342,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[94],"tags":[28759,13390,15329,28758,28757,28760],"miestas":[],"class_list":["post-37341","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finansai","tag-bioterorizmas","tag-moderna","tag-mrnr-vakcinos","tag-pandemiju-pasirengimas","tag-stephane-bancel","tag-vezio-vakcinos"],"acf":[],"_links":{"self":[{"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/posts\/37341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/comments?post=37341"}],"version-history":[{"count":0,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/posts\/37341\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/media\/37342"}],"wp:attachment":[{"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/media?parent=37341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/categories?post=37341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/tags?post=37341"},{"taxonomy":"miestas","embeddable":true,"href":"https:\/\/cp.snarskis.lt\/index.php\/wp-json\/wp\/v2\/miestas?post=37341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}